Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhCC10 in Premature Neonates With Respiratory Distress Syndrome
NCT01941745Phase 2Completed
- Sponsor
- Tufts Medical Center
- Start
- Oct 2013
- Primary completion
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of uteroglobin in respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), chronic pulmonary insufficiency of prematurity (CPIP), sponsored by Tufts Medical Center. Started Oct 2013; status: completed.
02
Drugs
uteroglobin
03
Conditions
respiratory distress syndrome (RDS)bronchopulmonary dysplasia (BPD)chronic pulmonary insufficiency of prematurity (CPIP)
Beyond the preview
Go deeper on NCT01941745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941745.